BIVI
Price
$3.00
Change
+$0.10 (+3.45%)
Updated
Sep 19, 09:30 AM (EDT)
69 days until earnings call
ITOS
Price
$11.55
Change
-$0.03 (-0.26%)
Updated
Sep 19, 10:27 AM (EDT)
48 days until earnings call
Ad is loading...

BIVI vs ITOS

Header iconBIVI vs ITOS Comparison
Open Charts BIVI vs ITOSBanner chart's image
BioVie
Price$3.00
Change+$0.10 (+3.45%)
VolumeN/A
CapitalizationN/A
iTeos Therapeutics
Price$11.55
Change-$0.03 (-0.26%)
Volume$1K
CapitalizationN/A
View a ticker or compare two or three
BIVI vs ITOS Comparison Chart
Loading...
BIVI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ITOS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
BIVI vs. ITOS commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIVI is a Hold and ITOS is a StrongSell.

COMPARISON
Comparison
Sep 19, 2024
Stock price -- (BIVI: $2.90 vs. ITOS: $11.59)
Brand notoriety: BIVI and ITOS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BIVI: 27% vs. ITOS: 193%
Market capitalization -- BIVI: $17.74M vs. ITOS: $423.29M
BIVI [@Biotechnology] is valued at $17.74M. ITOS’s [@Biotechnology] market capitalization is $423.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $599.73B to $0. The average market capitalization across the [@Biotechnology] industry is $3.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIVI’s FA Score shows that 1 FA rating(s) are green whileITOS’s FA Score has 1 green FA rating(s).

  • BIVI’s FA Score: 1 green, 4 red.
  • ITOS’s FA Score: 1 green, 4 red.
According to our system of comparison, ITOS is a better buy in the long-term than BIVI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIVI’s TA Score shows that 4 TA indicator(s) are bullish while ITOS’s TA Score has 4 bullish TA indicator(s).

  • BIVI’s TA Score: 4 bullish, 2 bearish.
  • ITOS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BIVI is a better buy in the short-term than ITOS.

Price Growth

BIVI (@Biotechnology) experienced а +0.35% price change this week, while ITOS (@Biotechnology) price change was -27.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.81%. For the same industry, the average monthly price growth was +7.77%, and the average quarterly price growth was +2.01%.

Reported Earning Dates

BIVI is expected to report earnings on Nov 27, 2024.

ITOS is expected to report earnings on Nov 06, 2024.

Industries' Descriptions

@Biotechnology (+7.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ITOS($423M) has a higher market cap than BIVI($17.7M). ITOS YTD gains are higher at: 5.845 vs. BIVI (-76.984). BIVI has higher annual earnings (EBITDA): -32.5M vs. ITOS (-136.64M). ITOS has more cash in the bank: 571M vs. BIVI (11.3M). ITOS has less debt than BIVI: ITOS (5.52M) vs BIVI (8.42M). ITOS has higher revenues than BIVI: ITOS (35M) vs BIVI (0).
BIVIITOSBIVI / ITOS
Capitalization17.7M423M4%
EBITDA-32.5M-136.64M24%
Gain YTD-76.9845.845-1,317%
P/E RatioN/AN/A-
Revenue035M-
Total Cash11.3M571M2%
Total Debt8.42M5.52M153%
FUNDAMENTALS RATINGS
BIVI: Fundamental Ratings
BIVI
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BIVIITOS
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 8 days ago
85%
Bullish Trend 10 days ago
76%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 4 days ago
78%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
BIVI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ITOS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PMVFX24.97N/A
N/A
PGIM Quant Solutions Mid-Cap Val R4
LEGGX12.16-0.01
-0.08%
BrandywineGLOBAL - Small Cap Value Is
EQNSX22.12-0.03
-0.14%
MFS Equity Income R2
GLPIX36.28-0.09
-0.25%
Goldman Sachs MLP Energy Infras Inv
TENWX11.19-0.04
-0.36%
Nuveen Emerging Markets Eq Idx W

BIVI and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIVI has been loosely correlated with SCNI. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if BIVI jumps, then SCNI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIVI
1D Price
Change %
BIVI100%
-1.69%
SCNI - BIVI
34%
Loosely correlated
+33.24%
ERAS - BIVI
28%
Poorly correlated
N/A
ITOS - BIVI
27%
Poorly correlated
-4.33%
CRSP - BIVI
26%
Poorly correlated
-0.64%
CRDF - BIVI
25%
Poorly correlated
-2.76%
More

ITOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ITOS has been loosely correlated with RCUS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ITOS jumps, then RCUS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITOS
1D Price
Change %
ITOS100%
-4.33%
RCUS - ITOS
44%
Loosely correlated
-1.43%
BMRN - ITOS
42%
Loosely correlated
+0.84%
FUSN - ITOS
41%
Loosely correlated
N/A
ADMA - ITOS
40%
Loosely correlated
+3.26%
NVAX - ITOS
39%
Loosely correlated
-2.94%
More